Danish pharma giant Novo Nordisk teased promising early-stage trial results of its experimental weight loss capsule amycretin, sending the corporate’s stock surging.Amazon will get in on it, a pill additional powerful than copyright, and many competition: Weight loss prescription drugs roundupLike other GLP-1 remedies, Zepbound will come with the